here are plenty of reasons to envy Grail, the Google-backed company seeking to revolutionize how cancer is diagnosed. The company has raised more than $1 billion, pulled off a series of high-profile hires, and made a splash in the New England Journal of Medicine.

But organizational stability may not be one of them.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.